Ultimele actualizari :
22/08/2024
Infostab
Listele
Listele
Cercetări de compatibilitate
Tabel de compatibilitate Y-site
Bibliografie
Echipe de cercetare
valistab
poster
Conexiuni
sponsori
Autor
Mod de utilizare
Newsletter
Ursodesoxycholique acid
Formula chimica
Bibliografie : Ursodesoxycholique acid
tip
publicare
2410
ziar
Johnson CE, Streetman DD.
Stability of oral suspensions of ursodiol made from tablets
Am J Health-Syst Pharm 2002 ; 59: 361-363.
2449
ziar
Johnson CE, Nesbitt J.
Stability of ursodiol in an extemporaneously compounded oral liquid
Am J Health-Syst Pharm 1995 ; 52: 1798-1800.
3782
ziar
A. Santove?a, E. S?nchez-Negr?n, L. Charola, M. Llabr?s, J.B. Fari?a
Study of quality and stability of ursodeoxycholic acid formulations for oral pediatric administration
Int J Pharm 2014 , 477, 1-2 : 32-38.
4177
ziar
Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A.
Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4.
Int J Pharm Compound 2018 ;22,6:516-526
4214
ziar
Pramar Y.V, Mandal T.K, Bostanian L.A, Nguyen A.TQ, Miller V, Morris T.C, Graves R.A.
Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt.
Int J Pharm Compound 2019 ;23,1:70-76
4498
ziar
Hausherr A, Roessle C, Pinet E, Vasseur V, Abarou T, Benakouche S, Bourdon O, Storme T.
Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns.
Pharmaceutical Technology in Hospital Pharmacy 2020
Mentions Légales